Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
August 27, 2001
- Nosan Corporation Ties Up with Midwest Research Institute
August 27, 2001
- Quality Reevaluation Enters Step 4 for 28 Ingredients
August 27, 2001
- MEDICAL DEVICE NEWS IN BRIEF
August 27, 2001
- Kirin Forms Research Alliance with Hyseq
August 27, 2001
- Use of Orange Book, Rx in Generic Name Recommended for Promotion of Generics: EAD Director
August 27, 2001
- Fujirebio, diaDexus Tie Up to Develop Cancer Diagnostic Agents
August 27, 2001
- Alendronate to Change Market for Osteoporosis
August 27, 2001
- REGULATORY NEWS IN BRIEF -1-
August 27, 2001
- Genzyme to Switch to Quatro Test for Maternal Serum Testing
August 27, 2001
- Contract MRs Are Being Rapidly Accepted: Apo Plus Station President
August 27, 2001
- Korosho to Start Model Project to Set Up Network of Electronic Medical Charts
August 27, 2001
- BULLETIN
August 27, 2001
- BUSINESS NEWS IN BRIEF -1-
August 27, 2001
- Errors in Medical Bills Related to Patients' ID Increasing
August 27, 2001
- REGULATORY NEWS IN BRIEF -2-
August 27, 2001
- BUSINESS NEWS IN BRIEF -2-
August 27, 2001
- Number of Long-term Care Beds Up to 5,837
August 27, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
August 27, 2001
- IFN Alphacon-1 Recommended for Approval
August 27, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…